Since 1990, POSITIVELY AWARE has been the most trusted source of HIV treatment news. It is the only HIV/AIDS treatment journal published by a 501(c)3 not-for-profit AIDS service organization (ASO)—Test Positive Aware Network (TPAN) in Chicago.
POSITIVELY AWARE provides accurate, up-to-date treatment information for people living with HIV/AIDS and their caregivers. We cover, in detail, all of the most important medical conferences—CROI, ICAAC, and the International AIDS Conference. The magazine serves as an educational tool for many HIV caregivers and helps to provide their clients with the best treatment information available. And Positively Aware is read by influential HIV researchers and policy makers.
Recognized professionals in the field of HIV/AIDS, many of our contributing writers volunteer their services to the magazine and to the HIV community. They include top-tier HIV specialist physicians and researchers from around the country, people living with HIV, and HIV/AIDS advocates.
The annual HIV Drug Guide
Since its first edition in 1997, POSITIVELY AWARE’s annual HIV Drug Guide is our most popular issue. The HIV Drug Guide is an A to Z reference to all FDA approved antiretroviral drugs, as well as those nearing approval. Included are tips on how to use the drugs, side effect and drug interaction charts, and a pull-out drug chart. What distinguishes the HIV Drug Guide is its insightful comments on each drug from both a nationally respected HIV physician and a community activist. Many people with HIV, their case managers, and doctors hold on to their copy of the HIV Drug Guide, referring to it throughout the year.
A new resource—the Hepatitis C (HCV) drug guide
To address new and changing treatments for hepatitis, POSITIVELY AWARE introduced the Hepatitis C Drug Guide in 2013. Similar to the HIV Drug Guide, this resource focuses on hepatitis C and co-infection with HIV. The HCV Drug Guide is so highly sought after, it is surpassed only by the HIV Drug Guide itself.